TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹157 Cr | ₹151 Cr | ₹129 Cr | ₹123 Cr | ₹130 Cr |
What is the latest Contingent Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹157 Cr |
Mar2023 | ₹151 Cr |
Mar2022 | ₹129 Cr |
Mar2021 | ₹123 Cr |
Mar2020 | ₹130 Cr |
How is Contingent Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹157 Cr | 4.38 | |
Mar2023 | ₹151 Cr | 17.16 | |
Mar2022 | ₹129 Cr | 4.76 | |
Mar2021 | ₹123 Cr | -5.34 | |
Mar2020 | ₹130 Cr | - |
Compare Contingent Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹112,878.4 Cr | 2.8% | 2.3% | 22.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹441,910.0 Cr | 5.4% | 3.2% | 20.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,035.0 Cr | 1.9% | 2% | 59.4% | Stock Analytics | |
CIPLA | ₹125,540.0 Cr | 1.7% | 2% | 13.2% | Stock Analytics | |
MANKIND PHARMA | ₹105,587.0 Cr | -0.6% | 7.9% | 6.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,110.0 Cr | 2.1% | -0.9% | -1.5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 2.8% |
2.3% |
22.8% |
SENSEX | 1% |
4.3% |
8.9% |
You may also like the below Video Courses